NCT06013215

Brief Summary

The cochlear implant provides good auditory performance despite high inter-individual variability, but performance in noise remains limited. Modification of the coding strategies could improve these performances. A better characterization of the remaining neuronal population by looking for the charge integration efficiency (which depends on the duration and the amplitude of the electrical pulse) would allow an optimization of the settings by adapting either the duration or the amplitude of the pulse according to the quality of the remaining neuronal population.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 28, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 28, 2023

Status Verified

August 1, 2023

Enrollment Period

2 years

First QC Date

July 27, 2023

Last Update Submit

August 25, 2023

Conditions

Keywords

hearing losscochlear implantpsychoacousticcharge integration efficiency

Outcome Measures

Primary Outcomes (1)

  • Calculate the charge integration efficiency along the electrodes

    Charge integration efficiency will be determined for each electrode by noting the minimum and maximum loudness perceived by the patient as function of pulse phase duration and amplitude

    4 hours

Secondary Outcomes (1)

  • Questionnaire between Intensity discrimination and charge integration efficiency

    4 hours

Study Arms (1)

Cochlear implant users with Neuro Zti array

EXPERIMENTAL

Post-lingually cochlear implant users with 12 months of auditory experience Modifications of pulse parameters to determine the charge integration efficiency which is related with neuron survival population

Other: Cochlear implant (Oticon) stimulation parameter optimization

Interventions

The pulse amplitude and/or the pulse phase duration will be optimize to improve the intensity resolution of the cochlear implant which may benefit speech perception

Cochlear implant users with Neuro Zti array

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • post-lingually deaf adults with at least one year of cochlear implant experience
  • unilateral and bilateral cochlear implant recipients
  • Oticon device with Neuro Zti array
  • Patient affiliated to french social security
  • Consent signed

You may not qualify if:

  • Patients under court protection, guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hearing Loss, SensorineuralHearing Loss

Interventions

Cochlear Implants

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Neural ProsthesesImplantable NeurostimulatorsElectrodes, ImplantedElectrodesElectrical Equipment and SuppliesEquipment and SuppliesProstheses and ImplantsHearing AidsSensory Aids

Study Officials

  • David Bakhos

    University Hospital, Tours

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David Bakhos, MD, PhD

CONTACT

Elodie MOUSSET, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2023

First Posted

August 28, 2023

Study Start

November 1, 2023

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

August 28, 2023

Record last verified: 2023-08